M&A Update – May 7

– CPRX to be acquired by Angelini Pharma for $31.50 cash per share, 21.4% premium, $4.1 billion
– CCRN to be acquired by Knox Lane for $13.25 cash per share, 31.1% premium, $437 million
– PKST / BAM deal closed
– CWAN shareholders approved Permira / Warburg Pincus buyout, waiting on Australia FIRB, closing Q2 2026
– CNTA / LLY filed DEFM14a, vote June 12, filed HSR Apr 21, closing Q3 2026
– KVUE / KMB filed China SAMR
– MPX / MCFT cleared HSR Apr 6, closing Q2 2026
– BLD / QXO filed Competition Canada
– SES.to / GFL.to cleared HSR, filed Competition Canada
– AFBI / Fidelity BancShares filed PREM14a, closing Q3 2026
– EWCZ vote
– GIG deal vote